Navigation Links
Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting
Date:4/15/2008

CALGARY, April 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced that an oral presentation by Dr. Chandini Thirukkumaran of the Tom Baker Cancer Centre, Calgary, entitled "Targeting Multiple Myeloma with Oncolytic Viral Therapy" was presented today at the American Association for Cancer Research (AACR) Annual Meeting. The meeting is being held in San Diego, California from April 12-16, 2008.

The presentation covered preclinical work using reovirus as a purging agent during autologous (harvested from the patient themselves) hematopoietic stem cell transplants for multiple myeloma. The results demonstrated that up to 70% of multiple myeloma cell lines tested showed reovirus sensitivity and reovirus induced cell death mediated through apoptosis.

The investigators concluded that this preclinical data supports initiating a Phase I purging trial using reovirus against multiple myeloma.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the implication of the materials presented at this meeting with respect to REOLYSIN(R), the Company's expectations related to the results of trials investigating delivery of REOLYSIN(R), and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainti
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...FirstCall/ -- Schering-Plough,Corporation (NYSE: ...,Friday, May 16, 2008, in Memphis, Tenn. At 8 a.m.... the meeting will be available to all interested,p...ering-plough.com ., At the Annual Meeting, Fred H...rs on the company,s performance and the progress b...
(Date:5/9/2008).../ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ON...patient enrolment in a clinical trial using intrav... with cyclophosphamide, a chemotherapeutic agent,a...ced cancers. The,Principal Investigators are Dr. J...n de Bono and Dr. Kevin Harrington of The Royal Ma...
(Date:5/9/2008)...e International Center for Adult,Stem Cell Educati... announced that,it has officially launched a globa...program at the 3rd International Spinal Cord Injur... Rehabilitation to be held today, May,9th, through...ASCE will be,headquartered in Fort Worth, Texas, w...
(Date:5/9/2008)...swire-FirstCall/ -- China-Biotics,Inc. (OTC Bulle... a leading,Chinese firm specializing in the manufa...bution of probiotics products, today announced it,... Qing Pu, Shanghai., "The new plant which has a 1...rategy. We have put over 1,000 pilings in the grou...
Breaking Biology Technology:Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial 2Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial 3International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece 2China-Biotics, Inc. Completes Foundation for Its New Plant 2
...inding information technology workers, Bruce Maas ... but his very public employer has found a way to a..., interim CIO at the University of Wisconsin-Milw...nation is going to address what New York Times c...crisis," the lack of young people on the science a...
...ility of crushing seeds and extracting raw meal fo...igation funded by $60,000 from the State of Wiscon...d an agricultural business in Dane County the gran...y in soybean, sunflower, and canola seeds for farm...laboration with Great Lakes BioFuels, LLC and ot...
...esearch into certain forms of cancer has focused o...on of blood. As these studies progress, significan...in changes induced by cancer but changes in the su...ins. , ,In the serum of pancreatic cancer patients...bohydrate structures that could be implicated in t...
...sition of a facility in Reno, Nev., commercial pri... capabilities to the west coast. , ,Quad, which of... clients, purchased Craftsman Press West, a privat...ally distributed magazines, catalogs, and retail i...nt. , ,The purchase will expedite distribution but...
Other Biology Technology:CIO Leadership Series: Bruce Maas, UWM 2CIO Leadership Series: Bruce Maas, UWM 3CIO Leadership Series: Bruce Maas, UWM 4GenTel licenses next generation cancer research 2GenTel licenses next generation cancer research 3
(Date:5/9/2008)...ner coaches law enforcement agents, supports CFCE ...er coaching, SOUTHFIELD, Mich., May 9 /PRNewswire...nced today that it will be lending Ed Moore, one o... working to become,Certified Forensics Computer Ex...s been with the CCF for 3 years, will lend his 8 y...
(Date:5/9/2008)...GE Theres no doubt about it ... the platypus is o...With adaptations like webbed feet to fit its aquat...les, the platypus represents for many a patchwork ... along with an international consortium of scienti...Saint Louis, Mo., has taken this theory to an enti...
(Date:5/9/2008)...alysis, published in the latest issue of Nature Ge...dy participants. It verifies two already known gen...they explain a difference in body size of about 3....ogically insightful findings. Several of the ident...ich affects the regulation of other genes. This co...
(Date:5/9/2008)...alif. - The radioactive carbon-14 produced by abov... helped researchers determine that the number of f... is established during the teenage years. Changes ...to changes in fat cell volume, not an increase in ...could help researchers develop new pharmaceuticals...
Breaking Biology News(10 mins):Center for Computer Forensics Offers Expert to Volunteer as CFCE Certification Applicants Coach 2First analysis of platypus genome may impact disease prevention 2How body size is regulated 2New technique determines the number of fat cells remains constant in all body types 2New technique determines the number of fat cells remains constant in all body types 3September Geology and GSA Today media highlights 170 1September Geology and GSA Today media highlights 170 2September Geology and GSA Today media highlights 170 3September Geology and GSA Today media highlights 170 4September Geology and GSA Today media highlights 170 5September Geology and GSA Today media highlights 170 6September Geology and GSA Today media highlights 170 7September Geology and GSA Today media highlights 170 8September Geology and GSA Today media highlights 170 9September Geology and GSA Today media highlights 170 10September Geology and GSA Today media highlights 170 11September Geology and GSA Today media highlights 170 12Cardinal Health Establishes 241 Million Grant Fund for Initiatives That Improve Quality Safety of Patient Care 228 1Cardinal Health Establishes 241 Million Grant Fund for Initiatives That Improve Quality Safety of Patient Care 228 2Cardinal Health Establishes 241 Million Grant Fund for Initiatives That Improve Quality Safety of Patient Care 228 3Treating Diabetes During Pregnancy Could Lead to Thinner Kids 218 1Treating Diabetes During Pregnancy Could Lead to Thinner Kids 218 2Discovery may help defang viruses 169 1Discovery may help defang viruses 169 2Discovery may help defang viruses 169 3
...on generally involves acquiring “received knowledg...s of scholars and scientists. But University of No...rew Pierce went beyond the textbooks and uncovered...y has to do with detecting a significant new detai... – perhaps the most studied and economically impor...
...ht all along, especially when we were hormone-ragi...l happen. , In a new physiological study of birds...nd that carotenoids, the pigments that color carro... benefits than originally thought. They appear to ...an have on an animal’s health. , The researche...
...K Roper Public Affairs survey sponsored by CancerC...ion, while the majority (76 percent) of women surv...reast cancer, many remain unaware of the important...e out of four (23 percent) women ages 50-65 have h... a gap between awareness and information that wome...
... the link between genetic factors and certain adve...tudy, published in the July 15th issue of The Jour...may have implications for predicting adverse event... infectious agents has been one of the greatest su... smallpox from the world is considered by some to ...
Other Biology News:Undergraduate research shows leaderless honeybee organizing 2Undergraduate research shows leaderless honeybee organizing 3Undergraduate research shows leaderless honeybee organizing 4ASU research shows connection between testosterone, dietary antioxidants and bird coloration 2Women well informed about breast cancer, yet lacking knowledge about current treatments 2Genetic factors are linked to fever following smallpox vaccination 2
All-in-one mix, removes primers and dNTPs from PCR product for following direct sequencing
Silencer Validated siRNA - with sequence information 5 nmol from Ambion
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
... are designed to rapidly and reliably amplify unkn.... APAgene provides hassle-free, ready-to use compo...l necessary ingredients are provided in each kit. ...rt-end amplification of large clones such as P1, Y...
Biology Products: